Elizabeth Cermak - Dec 12, 2021 Form 4 Insider Report for Clarus Therapeutics Holdings, Inc. (CRXT)

Role
Director
Signature
/s/ Steven A. Bourne, attorney-in-fact
Stock symbol
CRXT
Transactions as of
Dec 12, 2021
Transactions value $
$0
Form type
4
Date filed
12/14/2021, 06:00 PM
Previous filing
Sep 13, 2021
Next filing
Jun 9, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CRXT Common Stock Award $0 +3.84K $0.00 3.84K Dec 12, 2021 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CRXT Stock Option (Right to Buy) Award $0 +9.61K $0.00 9.61K Dec 12, 2021 Common Stock 9.61K $4.78 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The Reporting Person was granted a Restricted Stock Unit under the Issuer's 2021 Stock Option and Incentive Plan (the "2021 Plan") for 3,844 shares on 12/12/2021, which vests in equal annual installments over three years from the date of grant subject to the Reporting Person having a service relationship as of each such vesting date.
F2 These options were granted under the 2021 Plan and vest in equal annual installments over a period of three years from the date of grant subject to the Reporting Person having a service relationship as of each such vesting.